Background Meropenem is a broad-spectrum carbapenem-type antibiotic commonly used to treat critically ill patients infected with extended-spectrum β-lactamases (ESBL)-producing Enterobacteriaceae. As many of these require extracorporeal membrane oxygenation (ECMO) and/or continuous renal replacement therapy (CRRT), it important understand how life support circuits impact meropenem pharmacokinet...
